Authors: Llerena, A Berecz, R Norberto, MJ de la Rubia, A

Citation: A. Llerena et al., Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 755(1-2), 2001, pp. 349-354

Authors: Llerena, A Berecz, R de la Rubia, A Fernandez-Salguero, P Dorado, P

Citation: A. Llerena et al., Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes, THER DRUG M, 23(6), 2001, pp. 616-620

Authors: Berecz, R Glaub, T Kellermann, M de la Rubia, A Llerena, A Degrell, I

Citation: R. Berecz et al., Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient, PHARMACOPS, 33(1), 2000, pp. 42-44

Authors: Llerena, A Berecz, R de la Rubia, A Norberto, MJ Benitez, J

Citation: A. Llerena et al., Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity, THER DRUG M, 22(4), 2000, pp. 397-401

Authors: Carrillo, JA Ramos, SI Herraiz, AG Llerena, A Agundez, JAG Berecz, R Duran, M Benitez, J

Citation: Ja. Carrillo et al., Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients, J CL PSYCH, 19(6), 1999, pp. 494-499